Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-α production

Endocrinology

Volumn 137, Issue 11, 1996, Pages 4611-4618

  Renier, Geneviève ^a   Clément, Isabelle ^a   Desfaits, Anne Cécile ^a   Lambert, Anick ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0029806068     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.11.8895324     Document Type: Article

References (56)

1. Clark R, Shasser J, McCabe S, Robbins K, Jardien P 1993 Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest 92:540-548
2. Kincade PW 1994 B lymphopoiesis: global factors, local control. Proc Natl Acad Sci USA 91:2888-2889
3. Meltzer MS, Skillman DR, Hoover DL, Hanson BD, Turpin JA, Kalter DC, Gendelman HE 1990 Macrophages and the human immunodeficiency virus. Immunol Today 11:217-223
4. Kelley K 1990 The role of growth hormone in the modulation of the immune response. Ann NY Acad Sci 594:95-118
5. Bjerknes R, Aarskog D 1995 Priming of human polymorphonuclear neutrophilic leukocytes by insulin-like growth factor I: increased phagocytic capacity, complement receptor expression, degranulation, and oxidative burst. J Clin Endocrinol Metab 80:1948-1955
6. Wiedermann CJ, Reinisch N, Braunsteiner H 1993 Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood 82:954-960
7. Rifici VA, Schneider SH, Khachadurian AK 1994 Stimulation of low-density lipoprotein oxidation by insulin and insulin-like growth factor I. Atherosclerosis 107:99-108
8. Hochberg Z, Hertz P, Maor G, Oiknine J, Aviram M 1992 Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein. Endocrinology 131:430-435
9. Daughaday WH, Rotwein P 1989 Insulin-like growth factor 1 and II: peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 10:68-91
10. Pierpaoli W, Baroini C, Fabris N, Sorkin E 1969 Reconstruction of antibody production in hormonally deficient mice by somatotrophic hormone, thyreotropic hormone and thyroxin. Immunology 16:217-230
11. Baroni CD, Fabris N, Bertoli G 1969 Effects of hormones on development and function of lymphoid tissues. Immunology 17:303-314
12. Nagy E, Berczi I, Friesen HG 1983 Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) 102:351-357
13. Kiess W, Doerr H, Eisl E, Butenandt O, Belohradsky BH 1986 Lymphocyte subsets and natural killer cell activity in growth hormone deficiency. N Engl J Med 314:321
14. Edwards III CK, Yunger LM, Lorence RM, Dantzer R, Kelley KW 1991 The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Immunology 88:2274-2277
15. Snow EC, Feldbush TL, Oaks JA 1981 The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes. J Immunol 126:161-164
16. Christ DM, Peake GT, Mackinnon LT, Sibbit WL, Kraner JC 1987 Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. Metabolism 36:1115-1117
17. Saxena QB, Saxena RK, Adler WH 1982 Regulation of natural killer activity in vivo. Int Arch Allergy Appl Immunol 67:169-174
18. Edwards III CK, Ghiasuddin SM, Schepper JM, Yunger LM, Kelley KW 1988 A newly defined property of somatotrophin: priming of macrophages for production of superoxide anion. Science 239:769-771
19. Edwards III CK, Ghiasuddin SM, Yunger LM, Lorence RM, Arkins S, Dantzer R, Kelley KW 1992 In vivo administration of recombinant growth hormone or gamma interferon activates macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect Immun 60:2514-2521
20. Edwards III CK, Lorence RM, Dunham DM, Arkins S, Yunger LM, Greager JA, Walter RJ, Dantzer R, Kelley KW 1991 Hypophysectomy inhibits the synthesis of tumor necrosis factor a by rat macrophages: partial restoration by exogenous growth hormone or interferon γ. Endocrinology 128:989-996
21. Inoue T, Saito H, Fukushima R, Inaba T, Lin M-T, Fukatsu K, Muto T 1995 Growth hormone and insulin-like growth factor I enhance host defense in a murine sepsis model. Arch Surg 130:1115-1122
22. 2. J Immunol 154:1909-1918
23. Warwick-Davies J, Lowrie DB, Cole PJ 1995 Growth hormone activation of human monocytes for superoxide production but not tumour necrosis factor production, cell adherence, or action against mycobacterium tuberculosis. Infect Immun 63:4312-4316
24. Rom WN, Basset P, Fells GA, Nukiwa T, Trapenell BC, Crystal RG 1988 Alveolar macrophages release an insulin-like growth factor I-type molecule. J Clin Invest 82:1685-1692
25. 125I-somatomedin receptors on circulating human mononuclear cells. Biochem Biophys Res Commun 74:1566-1571
26. Kozak RW, Haskell JF, Greenstein LA, Rechler MM, Woldman TA, Nissley SP 1987 Type I and II insulin-like growth factor receptors on human phytohemagglutinin activated T-lymphocytes. Cell Immunol 109:318-331
27. Geffner ME, Bersch N, Lippe BM, Rosenfeld RG, Hintz RL, Golde DW 1990 Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I. J Clin Endocrinol Metab 71:464-469
28. Cox G, Gandino L, Blasi E, Radzioch D, Matheison BJ, Varesio L 1989 Heterogeneity of hematopoietic cells immortalized with v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst 81:1492-1496
29. Sheehan KCF, Ruddle NH, Schreiber RD 1989 Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 142:3884-3893
30. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
31. Thomas P 1980 Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201-5205
32. Bradford MM 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 72:248-254
33. Flier JS, Usher P, Moses AC 1986 Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83:664-668
34. Rechler MM, Nissley SP 1985 The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47:425-442
35. Soos MA, Field CE, Lammers R, Ullrich A, Zhang B, Roth RA, Andersen AS, Kjeldsen T, Siddle K 1992 A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem 267:12955-12963
36. Steele Perkins G, Roth RA 1990 Monoclonal antibody alpha IR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding. Biochem Biophys Res Commun 171:1244-1251
37. Kato H, Faria TN, Stannard B, Roberts CTJ, LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I mimetic antibody (alpha IR-3). J Biol Chem 268:2655-2661
38. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
39. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y 1987 Genistein, a specific inhibitor of tyrosine specific protein kinase. J Biol Chem 262:5592-5595
40. Gazit A, Yaish P, Gilon C, Levitzki A 1989 Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32:2344-2352
41. Lepidi H, Ciubotariu R, Bongrand P, Capo C, Barot-Ciorbaru Mege JL 1994 Protein tyrosine kinases and TNFα secretion in human monocytes. Int J Immunopharmacol 16:407-412
42. English BK, Ihle JN, Myracle A, Yi T 1993 Hck tyrosine kinases activity modulates tumor necrosis factor production by murine macrophages. J Exp Med 178:1017-1022
43. Scholl PR, Trede N, Chatila TA, Geha RS 1992 Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1. J Immunol 148:2237-2241
44. Scholl PR, Ahern D, Geha RS 1992 Protein tyrosine phosphorylation induced via the IgG receptors Fc-γRI and FcγRII in the human monocytic cell line, THP-1. J Immunol 149:1751-1757
45. Weinstein SL, Gold MR, De Franco AL 1991 Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 88:4148-4152
46. Hambleton J, McMahon M, DeFranco AL 1995 Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. J Exp Med 182:147-154
47. Shakhov AN, Collart MA, Vassali P, Nedospasov SA, Jongeneel CV 1990 KB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumour necrosis factor α gene in primary macrophages. J Exp Med 171:35-47
48. Han J, Brown T, Beutler B 1990 Endotoxin-responsive sequences control cachectin/TNF biosynthesis at the translational level. J Exp Med 171:465-475
49. Bertrand F, Philippe C, Antoine PJ, Baud L, Groyer A, Capeau J, Cherqui G 1995 Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway. J Biol Chem 270:24435-24441
50. Iwasaki T, Uehara Y, Graves L, Rachie N, Bomszryk K 1992 Herbimycin A blocks IL-1-induced NF-kappa B DNA binding activity in lymphoid cell lines. FEBS Lett 298:240-244
51. Joshi-Barve SS, Rangnekor VV, Sells SF, Rangnekor VM 1993 Interleukin-1-inducible expression of gro-beta via NF-kappa B activation is dependent upon tyrosine kinase signaling. J Biol Chem 268:18018-18029
52. Park JH, Levitt L 1993 Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP!, NF-AT, and NF-KB. Blood 82:2470-2477
53. Chaudhri G, Clark IA 1989 Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumour necrosis factor. J Immunol 143:1290-1294
54. Eshet R, Werner H, Klinger B, Silbergeld A, Laron Z, LeRoith D, Roberts, Jr, CT 1993 Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. J Mol Endocrinol 10:115-120
55. Rosenfeld RG, Hintz RL 1980 Characterization of a specific receptor for somatomedin C (Sm-C) on cultured human lymphoblasts: evidence that Sm-C modulates homologous receptor concentration. Endocrinology 107:1841-1848
56. Rosenfeld RG 1982 Characterization of the somatomedin-c/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentration by SM-C/ IGF-I and insulin. J Clin Endocrinol Metab 55:434-440